Victory Capital Management Inc Next Cure, Inc. Transaction History

Victory Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$9.47 - $12.43 $343,581 - $450,972	-36,281 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$8.15 - $21.17 $116,626 - $302,942	-14,310 Reduced 28.29%	36,281 $319,000
Q2 2020 Aug 07, 2020	SELL	$21.19 - $40.2 $4,619 - $8,763	-218 Reduced 0.43%	50,591 $1.09 Million
Q1 2020 May 04, 2020	SELL	$32.32 - $58.37 $101,775 - $183,807	-3,149 Reduced 5.84%	50,809 $1.88 Million
Q4 2019 Feb 06, 2020	BUY	$25.0 - $92.22 $71,600 - $264,118	2,864 Added 5.61%	53,958 $3.04 Million
Q4 2019 Feb 04, 2020	BUY	$25.0 - $92.22 $1.2 Million - $4.44 Million	48,161 Added 1642.04%	51,094 $2.18 Million
Q3 2019 Nov 12, 2019	SELL	$15.73 - $41.6 $4,545 - $12,022	-289 Reduced 8.97%	2,933 $90,000
Q2 2019 Aug 15, 2019	BUY	$14.16 - $20.64 $45,623 - $66,502	3,222 New	3,222 $48,000

15.9M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $31.4M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.